AMP Capital Investors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
EAM
CTA
EA
EMFAT
AMP Capital Investors's NEO Position: Q1 2019 in Review
AMP Capital Investors sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 22,400 shares — an estimated $272K sold.
AMP Capital Investors first reported a position in NEO in Q2 2018 and held it in 2 quarters. The position peaked at $272K in Q4 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.
- AMP Capital Investors reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
- AMP Capital Investors sold 22,400 NeoGenomics shares in Q1 2019, an estimated $272K.
- AMP Capital Investors first reported a position in NeoGenomics in Q2 2018 and held it in 2 quarters.
- AMP Capital Investors's NeoGenomics position peaked at $272K in Q4 2018.
- 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.
Based on AMP Capital Investors's 13F filing for Q1 2019, filed 15 May 2019.